Callan JMB Inc. Stock Price, News & Analysis

Callan JMB (NASDAQ: CJMB) has established a new subsidiary, Callan JMB Services (India) Private Limited, to expand its logistics services in India. The company plans to open a temperature-controlled warehouse in Pune, Maharashtra capable of storing pharmaceuticals at various temperatures, including -80°C for tissue samples.

The subsidiary, incorporated on June 20, 2025, will facilitate pharmaceutical distribution within India and help Indian companies establish manufacturing operations in the U.S. The company has already secured an agreement with Walker's Pharmaceuticals and is collaborating with Brihans Natural Products for U.S. manufacturing setup and distribution services.

Callan JMB (NASDAQ: CJMB) successfully managed the redistribution of over 1,300 MMR II vaccine doses from Chicago's Westside CDC to Texas and New Mexico in response to measles outbreaks. The company utilized its specialized cold chain reusable shippers equipped with active temperature monitoring devices to maintain required temperatures during transit. The operation demonstrated efficient vaccine redistribution with zero waste, as all shipping materials were recovered and recertified, preventing any landfill disposal. COO Scott Bullard highlighted the operation as a model for interstate public health collaboration during outbreak responses, showcasing the company's cold chain technology capabilities in ensuring safe vaccine delivery.

Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, has announced its participation in Maxim Group's 2025 Virtual Tech Conference. The company will engage in a fireside chat on June 3, 2025, at 10:30 a.m. ET. The conference, themed "Discover the Innovations Reshaping Tomorrow," will run from June 3-5, 2025.

Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies. Interested parties can register through the provided link or contact KCSA Strategic Communications for meetings.

Callan JMB (NASDAQ: CJMB) has formed a strategic joint venture with Revival Health to enhance the U.S. supply chain for health, wellness, and longevity products. The partnership combines Callan JMB's expertise in cold chain logistics, data systems, and bioservices with Revival Health's consumer-first approach to preventive care. Through Callan JMB's operations arm, Coldchain Technology Services, the venture will provide comprehensive supply chain services including transportation, warehousing, QA/QC, data integration, and regulatory compliance. The collaboration aims to support both imported and U.S.-based manufacturing of healthcare products, focusing on creating scalable, compliant, and responsive distribution infrastructure for the growing preventive care and home health technologies market.

Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, reported its Q1 2025 financial results following its February IPO. The company raised $5.7 million through its IPO at $4.00 per share. Q1 2025 financial results showed revenue of $1.45 million, with a gross profit margin of 42.5%, but reported a net loss of $1.2 million due to increased SG&A expenses and declining emergency preparedness service demand.

Key developments include appointing Christopher Shields as SVP of Emergency Preparedness & Response, renewing contracts with Texas DSHS, securing a five-year contract with Oregon Health Authority, and launching a vaccine management lease program. The company is expanding into GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.

Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its upcoming participation in the Aegis Capital Corp. Virtual Conference scheduled for May 21, 2025. The company's management team will deliver a presentation at 1:00 p.m. ET. Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies.

Callan JMB (NASDAQ: CJMB) has appointed Christopher Shields as Senior Vice President of Emergency Preparedness & Response/Government Affairs. Shields, former Assistant Commissioner of the Chicago Department of Public Health, brings over 14 years of experience managing the city's Emergency Preparedness and Bioterrorism program.

In his previous role, Shields managed the Tier 1 Medical Pharmacy operations, advanced vaccine inventory systems, and led critical functions including Continuity of Operations and Emergency Operations Planning. His extensive experience includes responding to major events such as 9/11, Hurricane Katrina, H1N1 Pandemic, and the COVID-19 crisis.

CEO Wayne Williams highlighted that Shields' appointment will help Callan JMB expand its emergency preparedness and response operations into new cities and states. The company currently provides integrative logistics services for healthcare industry and emergency management agencies, including fulfillment, storage, monitoring, and cold chain logistics services.

Callan JMB (NASDAQ: CJMB), a company specializing in integrative logistics for healthcare and emergency management agencies, has announced its participation in the upcoming LD Micro Invitational Conference in New York City.

The event will take place at the Westin Grand Central on April 9-10, 2025. The company's management team is scheduled to present on Thursday, April 10th at 3:30 p.m. ET in Track 3. The presentation will be accessible via webcast through the LD Micro platform.

Additionally, the management team will be available for one-on-one investor meetings during the conference, which can be arranged through LD Micro representatives or KCSA Strategic Communications.

Callan JMB (NASDAQ: CJMB), a logistics company specializing in healthcare and emergency management, reported its full year 2024 financial results. The company successfully completed its IPO on February 6, 2025, raising approximately $5.7 million at $4.00 per share.

Key financial metrics for 2024 include:

• Total revenue: $6.6 million ($3.8M from emergency response, $2.8M from specialty packaging)
• Gross profit: $2.6 million with 39.1% margin
• Operating loss: $2.3 million
• Net loss: $2.3 million

Notable achievements include extending arrangements with Texas DSHS, securing a five-year contract with Oregon Health Authority, launching a vaccine management lease program, and joining Complete Group Services. Revenue was impacted by reduced emergency preparedness services post-COVID and a temporary suspension of orders from one customer.